This $1,873,868 Project Grant award from the National Institute on Drug Abuse (NIDA), under CFDA 93.279 - Drug Use and Addiction Research Programs, aims to develop and evaluate an intervention to improve retention in substance use disorder (SUD) treatment for pregnant patients. The key products and services to be delivered include: Developing and piloting a standardized approach to identify and address social determinants of health (SDOH) that impact SUD treatment retention for pregnant...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), will develop and test digital helpline intervention components aimed at reducing heavy episodic drinking (HED) during the first 3 months postpartum. The $251,309 award will be used to apply the Multiphase Optimization Strategy (MOST) framework to develop standard helpline interventions, including assessment, psychoeducation, and links to...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development and evaluation of a mobile health (mHealth) intervention to provide psychosocial and self-management support for postpartum individuals recovering from opioid use disorder (OUD). The $174,378 award will fund the iterative development of an Acceptance and Commitment Therapy (ACT)-based mHealth intervention, incorporating a...
This $6,439,263 federal Project Grant awarded by the National Institute on Drug Abuse (CFDA 93.279 Drug Abuse and Addiction Research Programs) aims to determine the impact of maternal substance use on maternal immune activation, placental function, and offspring neurobehavioral development. The project will leverage the Healthy Brain and Child Development (HBCD) study to perform maternal immune profiling, placental and cord blood analysis, and novel neuroinflammation imaging on 400 pregnancies...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $390,635 to the University of Pittsburgh to conduct a multi-phase research project aimed at developing a novel intervention to reduce tobacco and cannabis use among pregnant and postpartum individuals, particularly those from minoritized groups. The project has three key objectives: 1) Conduct formative research on the experiences of marginalized...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $193,752 to Boston Medical Center Corporation to test the effectiveness of a video-coaching intervention called THRIVE in promoting positive parenting behaviors among mothers with opioid use disorder (OUD) and their preschool-aged children. The 5-year award, beginning on April 15, 2025, aims to address the urgent need to make...
This Project Grant from the National Institute on Drug Abuse, part of the Department of Health and Human Services, provides $738,086 to Brown University under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to evaluate a technology-assisted parenting intervention for adolescents in residential substance use treatment. Specifically, the funding supports a randomized controlled trial to test the effectiveness of Parent SMART, a mobile app and telehealth coaching program that...
This $945,397 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to adapt and evaluate a Collaborative Care Model (CCM) for treating pregnant and postpartum persons with opioid use disorder (OUD) in low-resource obstetric settings. The key objectives are to: 1) adapt an existing CCM for rural and low-resource obstetric sites; 2) create a common data model to harmonize data across study sites; 3)...
This Project Grant award, with a total funding of $180,059, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports a study titled "Optimizing Developmental Outcomes in Early Childhood After Neonatal Opioid Withdrawal Syndrome" at the Research Institute at Nationwide Children's Hospital (RINCH), a prominent non-profit research organization. The key objectives of this study are to: 1) engage with...
This $1,871,814 Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will establish a Patient Engagement Resource Center (PERC) to address disparities in substance use disorder (SUD) treatment engagement for parents. The key objectives are to: 1) Build a Lived Expertise Advisory Panel (LEAP) of 18 parents with SUD to support capacity building and decision making; 2) Conduct mixed-methods research to...
This $1,016,264 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to develop and evaluate digital screening and brief intervention (e-SBI) approaches for addressing perinatal substance use in home visiting programs. The project, led by the non-profit organization Partnership To End Addiction, will pilot test three e-SBI delivery strategies - a single session, a session plus booster, and post-session text messaging - to assess their impacts on postpartum substance use, maternal self-efficacy, and home visiting retention. Additionally, the project will evaluate the feasibility, acceptability, and fidelity of the e-SBI approaches, as well as identify implementation facilitators and barriers to inform the development of targeted strategies to support sustainable integration of e-SBI into routine home visiting services. This 3-year project, beginning in June 2024, represents an effort to leverage home visiting programs as a promising venue to reach and support high-risk postpartum mothers and prevent negative maternal and child health outcomes related to substance use.